Invited Commentary: Limitations and Usefulness of the Metabolically Healthy Obesity Phenotype

American Journal of Epidemiology

Volumn 182, Issue 9, 2015, Pages 742-744

  Bradshaw, Patrick T ^a,b   Stevens, June ^a,c  

^a University of North Carolina   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

metabolic syndrome; metabolically healthy obesity; obesity

Indexed keywords

ANTHROPOMETRY; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; HEALTH HAZARD; HUMAN; INTRAABDOMINAL FAT; METABOLICALLY HEALTHY OBESITY; NOTE; OBESITY; PHENOTYPE; RISK FACTOR; METABOLICALLY BENIGN OBESITY;

ADIPOSITY; ANTHROPOMETRY; BODY MASS INDEX; HUMANS; OBESITY; OBESITY, METABOLICALLY BENIGN; PHENOTYPE;

EID: 84947604263     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv178     Document Type: Note

References (23)

1. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617-1624.
2. Rey-López JP, de Rezende LF, Pastor-Valero M, et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15(10):781-790.
3. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14(3):219-227.
4. Phillips CM, Dillon C, Harrington JM, et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One. 2013;8(10):e76188.
5. Karelis AD. To be obese - does it matter if you are metabolically healthy? Nat Rev Endocrinol. 2011;7(12):699-700.
6. Rey-López JP, de Rezende LF, de Sá TH, et al. Is the metabolically healthy obesity phenotype an irrelevant artifact for public health? Am J Epidemiol. 2015;182(9):737-741.
7. Lu Y, Hajifathalian K, Rimm EB, et al. Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects. Epidemiology. 2015;26(2):153-162.
8. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-591.
9. Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring). 2011;19(3):624-630.
10. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2001;2(3):141-147.
11. Van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875-880.
12. Cui Z, Truesdale KP, Bradshaw PT, et al. Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: the Atherosclerosis Risk in Communities Study. Int J Obes (Lond). 2015;39(8):1203-1208.
13. Chang Y, Kim BK, Yun KE, et al. Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol. 2014;63(24):2679-2686.
14. Bell JA, Hamer M, Sabia S, et al. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101-102.
15. Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study. Obesity (Silver Spring). 2013;21(1):203-209.
16. Hwang YC, Hayashi T, Fujimoto WY, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype [published online ahead of print April 29, 2015]. Int J Obes (Lond). (doi:10.1038/ijo.2015.75).
17. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758-769.
18. Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014;15(6):504-515.
19. Fan J, Song Y, Chen Y, et al. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168(5):4761-4768.
20. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583-2589.
21. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199-211.
22. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation. 2014;129(25 suppl 2):S102-S138.
23. Stevens J, Bradshaw PT, Truesdale KP, et al. Obesity Paradox should not interfere with public health efforts. Int J Obes (Lond). 2015;39(1):80-81.